DE GIULI MORGHEN, CARLO
DE GIULI MORGHEN, CARLO
DIPARTIMENTO DI FARMACOLOGIA, CHEMIOTERAPIA E TOSSICOLOGIA MEDICA (attivo dal 01/01/1960 al 26/04/2012)
Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses
2024 A. Radaelli, C. Zanotto, C. Brambilla, T. Adami, F. Paolini, A. Venuti, A. Manuka, I. Mehmeti, C. De Giuli Morghen
Staphylococcus aureus RnpA Inhibitors: Computational-Guided Design, Synthesis and Initial Biological Evaluation
2021 L. Suigo, M. Chojnacki, C. Zanotto, V. Sebastián-Pérez, C. DE GIULI MORGHEN, A. Casiraghi, P.M. Dunman, E. Valoti, V. Straniero
RnpA inhibitors as potential antimicrobials to fight antibiotic-resistance: Computational design, synthesis, and biological evaluation
2021 L. Suigo, M. Chojnacki, C. Zanotto, V. Sebastián-Pérez, C. De Giuli Morghen, A. Casiraghi, P. Dunman, E. Valoti, V. Straniero
Construction of a recombinant avipoxvirus expressing the env gene of Zika virus as a novel putative preventive vaccine
2021 C. Zanotto, F. Paolini, A. Radaelli, C. De Giuli Morghen
Benzodioxane‐Benzamides as Antibacterial Agents : Computational and SAR Studies to Evaluate the Influence of the 7‐Substitution in FtsZ Interaction
2019 V. Straniero, V. Sebastián‐Pérez, M. Hrast, C. Zanotto, A. Casiraghi, L. Suigo, I. Zdovc, A. Radaelli, C. De Giuli Morghen, E. Valoti
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes
2018 M. Bissa, G. Forlani, C. Zanotto, G. Tosi, C. De Giuli Morghen, R.S. Accolla, A. Radaelli
Comparative Evaluation of the Collection Efficiency of Seven Different Air Samplers to Monitor Airborne Viable Microorganisms
2018 C. Zanotto, A. Radaelli, C. De Giuli Morghen
2,6-Difluorobenzamide Inhibitors of Bacterial Cell Division Protein FtsZ : Design, Synthesis, and Structure Activity Relationships
2017 V. Straniero, C. Zanotto, L. Straniero, A. Casiraghi, S. Duga, A. Radaelli, C. De Giuli Morghen, E. Valoti
Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses
2017 U. Sauermann, A. Radaelli, N. Stolte Leeb, K. Raue, M. Bissa, C. Zanotto, M. Krawczak, M. Tenbusch, K. Überla, B.F. Keele, C. De Giuli Morghen, S. Sopper, C. Stahl Hennig
3-(Benzodioxan-2-ylmethoxy)-2,6-difluorobenzamides bearing hydrophobic substituents at the 7-position of the benzodioxane nucleus potently inhibit methicillin-resistant Sa and Mtb cell division
2016 V. Straniero, M. Pallavicini, G. Chiodini, C. Zanotto, L. Volontè, A. Radaelli, C. Bolchi, L. Fumagalli, M. Sanguinetti, G. Menchinelli, G. Delogu, B. Battah, C. De Giuli Morghen, E. Valoti
Structure Activity Relationship of novel antimicrobial agents, acting as inhibitors of the bacterial cell division protein Ftsz
2016 V. Straniero, C. Zanotto, L. Fumagalli, C. Bolchi, A. Radaelli, F. Bavo, M. Sanguinetti, C. De Giuli Morghen, M. Pallavicini
Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X
2016 E. Illiano, M. Bissa, F. Paolini, C. Zanotto, C. De Giuli Morghen, R. Franconi, A. Radaelli, A. Venuti
Removal of enteric viruses and Escherichia coli from municipal treated effluent by zebra mussels
2016 V. Mezzanotte, F. Marazzi, M. Bissa, S. Pacchioni, A. Binelli, M. Parolini, S. Magni, F.M. Ruggeri, C. De Giuli Morghen, C. Zanotto, A. Radaelli
Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity
2016 M. Bissa, E. Quaglino, C. Zanotto, E. Illiano, V. Rolih, S. Pacchioni, F. Cavallo, C. De Giuli Morghen, A. Radaelli
Identification of antibiotic-resistant Escherichia coli isolated from a municipal wastewater treatment plant
2016 C. Zanotto, M. Bissa, E. Illiano, V. Mezzanotte, F. Marazzi, A. Turolla, M. Antonelli, C. De Giuli Morghen, A. Radaelli
Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: Implications for HPV-tumor diagnosis and therapy
2016 E. Illiano, O.C. Demurtas, S. Massa, P. Bonito, V. Consalvi, R. Chiaraluce, C. Zanotto, C. De Giuli Morghen, A. Radaelli, A. Venuti, R. Franconi
Novel inhibitors of the bacterial cell division protein FtsZ: synthesis and antibacterial activity
2015 V. Straniero, L. Fumagalli, C. Bolchi, C. Zanotto, P. Ruggeri, A. Radaelli, C. De Giuli Morghen, M. Pallavicini, E. Valoti
Benzodioxane–benzamides as new bacterial cell division inhibitors
2015 G. Chiodini, M. Pallavicini, C. Zanotto, M. Bissa, A. Radaelli, V. Straniero, C. Bolchi, L. Fumagalli, P. Ruggeri, C. De Giuli Morghen, E. Valoti
A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers
2015 M. Bissa, E. Illiano, S. Pacchioni, F. Paolini, C. Zanotto, C. De Giuli Morghen, S. Massa, R. Franconi, A. Radaelli, A. Venuti
The L1 protein of human papilloma virus 16 expressed by a fowlpox virus recombinant can assemble into virus-like particles in mammalian cell lines but elicits a non-neutralising humoral response
2015 M. Bissa, C. Zanotto, S. Pacchioni, L. Volonté, A. Venuti, D. Lembo, C. De Giuli Morghen, A. Radaelli